Libya vs Saint Vincent and the Grenadines: Current health expenditure (CHE) per capita in US$
Libya
470.4
in 2023
Saint Vincent and the Grenadines
469.21
in 2023
Libya rank
99th
Saint Vincent and the Grenadines rank
100th
Current health expenditure (CHE) per capita in US$ over time
- Libya
- Saint Vincent and the Grenadines
How they compare
Libya currently reports 470.4 against 469.21 in Saint Vincent and the Grenadines, a difference of 1.19.
The two have swapped places 2 times across 24 shared years of data; in 2000 it was Libya ahead.
Libya ranks 99th and Saint Vincent and the Grenadines ranks 100th of 194 countries.
Across the 3 decades both report, Libya averaged higher in 2 and Saint Vincent and the Grenadines in 1.
Head to head by decade
| Decade | Libya | Saint Vincent and the Grenadines | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 244.01 | 202.75 | 41.27 | Libya |
| 2010s | 479.63 | 314.09 | 165.54 | Libya |
| 2020s | 381.47 | 442.07 | 60.6 | Saint Vincent and the Grenadines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher current health expenditure (che) per capita in us$, Libya or Saint Vincent and the Grenadines?
- Libya, at 470.4 against 469.21 in Saint Vincent and the Grenadines as of 2023.
- What is the difference in current health expenditure (che) per capita in us$ between Libya and Saint Vincent and the Grenadines?
- 1.19, with Libya ahead.
- How many years of comparable data are there for Libya and Saint Vincent and the Grenadines?
- 24 years are reported by both, from 2000 to 2023.
- How do Libya and Saint Vincent and the Grenadines rank globally for current health expenditure (che) per capita in us$?
- Libya ranks 99th and Saint Vincent and the Grenadines ranks 100th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Current health expenditure (CHE) per capita in US$. Statizoid refreshes it automatically from the source and publishes the full history for both places.